Access cutting-edge myositis treatment through this clinical trial at a research site in Iowa City. Study-provided care at no cost to qualified participants.
Access myositis specialists in Iowa City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myositis treatment provided free
A Phase 2, randomized, open-label, controlled study to evaluate the efficacy and safety of rapcabtagene autoleucel versus comparator in participants with severe refractory idiopathic inflammatory myopathies (IIM)
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this myositis clinical trial in Iowa City, IA
If you're searching for myositis treatment options in Iowa City, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Iowa City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myositis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.